Income StatementBalance SheetCash FlowSegments
Johnson & Johnson logo

Johnson & Johnson Income Statement

Revenue, expenses, and profitability over time

Johnson & Johnson generated $96.4B in trailing twelve-month revenue, up 0.1% year-over-year. Net income was $21.0B with a 21.83% net margin. Diluted EPS is $8.64, which declined 0.0% year-over-year. Based on the Q1 2026 filing.

Total Revenue (TTM)$96.4BGross Profit (TTM)$65.4BNet Income (TTM)$21.0BEps Diluted (TTM)$8.64
Latest FilingQ1 2026
Report Date2026-04-22
Market Cap$564.11B
P/E Ratio26.81
ROE26.42%

Earnings Per Share

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Basic earnings per share$1.42$4.57$2.30$2.14$2.12$2.17
Diluted earnings per share$1.41$4.54$2.29$2.12$2.09$2.14
Weighted-average shares, basic—2.4B2.4B2.4B100K2.4B
Weighted-average shares, diluted—2.4B2.4B2.4B4.6M2.4B

Operating Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Gross profit$15.4B$14.5B$16.1B$16.7B$16.6B$16.0B

Other Income & Expense

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other Charges$0.0$7.3B-$107.0M$478.0M$0.0-$294.0M
Interest expense$137.0M$204.0M$308.0M$245.0M$214.0M$272.0M
Interest income$281.0M$332.0M$260.0M$227.0M$237.0M$229.0M

Income Before Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income before income taxes$3.9B$13.6B$6.5B$7.5B$5.0B$6.0B

Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income tax expense$456.0M$2.6B$954.0M$2.3B$0.0$755.0M

Net Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net income$3.4B$11.0B$5.5B$5.2B$5.1B$5.2B

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Cost of products sold percent to sales—33.6%32.1%30.4%—33.7%
Gross Profit Percent To Sales—66.4%67.9%69.6%—66.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Percent To Sales—62.3%27.3%31.2%—24.9%
Provision for taxes on income percent to sales—12.1%4.0%9.7%—3.1%
Interest expense, net of portion capitalized percent to sales—0.9%1.3%1.0%—1.2%
Interest income percent to sales—-1.5%-1.1%-0.9%—-1.0%
Other (income) expense, net percent to sales—-33.4%0.5%-2.0%—1.2%
Other income, net (Note 6)$0.0$7.3B-$107.0M$478.0M$0.0-$294.0M
Research and development expense$5.3B$3.2B$3.5B$3.7B$4.3B$3.5B
Research and development expense percent to sales—14.7%14.8%15.3%—14.7%
In-process research and development impairments$17.0M$0.0$0.0$0.0$81.0M$36.0M
In-process research and development percent to sales—0.0%0.0%0.0%—0.1%
Restructuring charge percent to sales—0.1%0.3%0.3%—0.1%
Revenue From Contract With Customer Excluding Assessed Tax$22.5B$21.9B$23.7B$24.0B$24.6B$24.1B
Sales to customers percent to sales—100.0%100.0%100.0%—100.0%
Selling marketing and administrative expenses percent to sales—23.3%24.8%24.7%—25.1%

Operating Expenses

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Restructuring charges$42.0M$17.0M$64.0M$63.0M$84.0M$32.0M
Selling, general and administrative$6.5B$5.1B$5.9B$5.9B$6.8B$6.0B

Cost of Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total cost of revenue$7.1B$7.4B$7.6B$7.3B$8.0B$8.1B

Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total revenue$22.5B$21.9B$23.7B$24.0B$24.6B$24.1B